Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Cemex Philippines IPO: Sound Industry Fundamentals, But Limited Upside

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Cemex Holdings Philippines / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/22701" target="_blank" data-smartkarma-citation="entities:22701">Cemex SAB De CV (ADR)</a> 's Philippines subsidiary <a href="https://www.smartkarma.com/entities/22700" target="_blank" data-smartkarma-citation="entities:22700">Cemex Holdings Philippines</a>  is planning to raise up to US$860m by June.In this insight, I look to answer the following questions:<ul><li>How is the company positioned in its market?</li><li>How does it fare versus its peers? </li><li>What are the key market trends one needs to be aware of? </li><li>Will the company's related party transactions be a concern?</li></ul>Once the deal is launched, we will re-evaluate the deal and run it through our framework in our next insight.

Cemex SAB De CV (ADR) 's Philippines subsidiary Cemex Holdings Philippines  is planning to raise up to US$860m by June.In this insight, I look to answer the following questions:How is the company positioned in its market?How does it fare versus its peers? What are the key market trends one needs to be aware of? Will the company's related party transactions be a concern?Once the deal is launched, we will re-evaluate the deal and run it through our framework in our next insight.

Cemex Philippines IPO Early Thoughts: Supply Glut, Notes on CG